Status:
COMPLETED
Lactoferrin Effect on Kidney and Heart of Rhabdomyolysis Rats
Lead Sponsor:
Aswan University Hospital
Conditions:
Rhabdomyolysis
Eligibility:
MALE
10-12 years
Phase:
PHASE4
Brief Summary
This study focuses on detecting the possible beneficial effect of Lactoferrin (Lf) administration on the kidney and the heart of glycerol-induced rhabdomyolysis (RM) in rats and its relation to ferrop...
Eligibility Criteria
Inclusion
- • Twenty-four healthy male Wistar Albino rats weighing from 250 to 300 g
Exclusion
- No exclusion criteria as this study is used to detect effects of drugs on experimental rats.
Key Trial Info
Start Date :
November 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2025
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT06491394
Start Date
November 1 2024
End Date
April 1 2025
Last Update
July 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Medicine
Aswān, Aswan Governorate, Egypt, 81528